Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02354378 · ClinicalTrials.gov registry record
A Pilot Study to Assess the Amnesic Properties of Dexmedetomidine in Pediatric Patients
A clinical trial, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 84
- Enrollment target
NCT02354378 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 84 participants.
The verdict
NCT02354378 has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 84 participants
- Enrollment target
Study Summary
The goal of this study is to determine the effects of dexmedetomidine on memory and recall of children who are receiving dexmedetomidine sedation administered for magnetic resonance imaging (MRI) studies. Dexmedetomidine is currently the standard drug for sedation for diagnostic (MRI, computerized tomography (CT) and Nuclear Medicine) radiological studies at Boston Children's Hospital (BCH). The effect of dexmedetomidine on memory and recall in children has not been studied.
Interventions
- DRUG Dexmedetomidine
- OTHER Memory Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2012-08 |
| Est. Completion | 2015-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02354378
The ClinicalTrials.gov registry entry for NCT02354378 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dexmedetomidine is the first listed.
NCT02354378 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02354378 about?
NCT02354378 is a clinical study titled "A Pilot Study to Assess the Amnesic Properties of Dexmedetomidine in Pediatric Patients". The goal of this study is to determine the effects of dexmedetomidine on memory and recall of children who are receiving dexmedetomidine sedation administered for magnetic resonance imaging (MRI) studies. Dexmedetomidine is currently the standard drug for sedation for diagnostic (MRI, computerized t...
What is the current status of trial NCT02354378?
This trial is currently completed. The enrollment target is 84 participants. The study started on 2012-08. Estimated completion is 2015-03.
What interventions are being tested in trial NCT02354378?
The interventions under investigation include: Dexmedetomidine (DRUG), Memory Test (OTHER).
Who is sponsoring clinical trial NCT02354378?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.